NCT06512389View on ClinicalTrials.gov

Evaluating Cannabidiol as a Novel Anticraving Medication for Alcohol Use Disorder

PHASE2RecruitingINTERVENTIONAL

Enrollment

36

Participants

Timeline

Start Date

August 16, 2024

Primary Completion Date

December 31, 2026

Study Completion Date

December 31, 2026

Conditions

Alcohol Use Disorder

Interventions

DRUG

Oral solution

300 mg taken morning and evening

Trial Locations (1)

M6J 1H4

RECRUITING

Centre for Addiction and Mental Health, Toronto

All Listed Sponsors

lead

Centre for Addiction and Mental Health

OTHER